Optimization of the culture condition for an antitumor bacterium Serratia proteamacula 657 and identification of the active compounds

World Journal of Microbiology and Biotechnology

Volumn 29, Issue 5, 2013, Pages 855-863

  Miao, Li ^a,b   Wang, Xueling ^a   Jiang, Wei ^a   Yang, Shengping ^b   Zhou, Huiru ^a   Zhai, Youpeng ^a   Zhou, Xiaojian ^a   Dong, Kunming ^a  

^a YANGZHOU UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Antitumor activity; Optimization of culture conditions; Prodigiosin; Serratia proteamacula

Indexed keywords

BIOMOLECULES; BIOTECHNOLOGY; FERMENTATION; MAGNESIUM COMPOUNDS; MARINE APPLICATIONS; METABOLITES; SODIUM CHLORIDE; TUMORS; YEAST;

ANTI-TUMOR ACTIVITIES; CULTURE CONDITIONS; LIQUID FERMENTATIONS; OPTIMIZED CONDITIONS; PHARMACEUTICAL APPLICATIONS; PRODIGIOSIN; SERRATIA; SOLID-STATE FERMENTATION;

BACTERIA;

BACTERIA (MICROORGANISMS); SERRATIA;

EID: 84875723724     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-012-1240-x     Document Type: Review

References (26)

1. Arthaud IDB, Rodrigues FAR, Jimenez PC, Montenegro RC, Angelim AL, Maciel VMM, Silveira ER, Freitas HPS, Sousa TS, Pessoa ODL, Lotufo TMC, Costa-Lotufo LV (2012) Studies on the secondary metabolites of a Pseudoalteromonas sp. isolated from sediments collected at the Northeastern coast of Brazil. Chem Biodiver 9(2): 418-427.
2. Bai R, Pettit GR, Hamel E (1990) Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain. Biochem Pharmacol 39: 1941-1949.
3. Blunt JW, Copp BR, Munro MHG, Northcote PT, Prinsep MR (2004) Marine natural products. Nat Prod Rep 21: 1-49.
4. Blunt JW, Copp BR, Hu W-P, Munro MHG, Northcote PT, Prinsep MR (2008) Marine natural products. Nat Prod Rep 25: 35-94.
5. Cang S, Sanada M, Johdo O, Ohta S, Nagamalsu Y, Yoshimoto A (2000) High production of prodigiosin by Serratia marcesceus grown on ethanol. Biotech Lett 22: 1761-1765.
6. Chang CC, Chen WC, Ho TF, Wu HS, Wei YH (2011) Development of natural anti-tumor drugs by microorganisms. J Biosic Bioeng 111(5): 501-511.
7. Demain AL, Zhang L (2005) Natural products and drug discovery. In: Zhang L, Demain A (eds) Natural products: drug discovery and therapeutics medicines. Humana Press, New Jersey, pp 3-32.
8. Francisco R, Pérez-Tomás R, Gimènez-Bonafé P, Soto-Cerrato V, Giménez-Xavier P, Ambrosio S (2007) Mechanisms of prodigiosin cytotoxicity in human neuroblastoma cell lines. Eur J Pharmacol 572(2-3): 111-119.
9. Furstner A (2003) Chemistry and biology of roseophilin and the prodigiosin alkaloids: a survey of the last 2500 years. Angew Chem Int Ed 42: 3582-3603.
10. Giri AV, Anandkumar N, Muthukumaran G, Pennathur G (2004) A novel medium for the enhanced cell growth and production of prodigiosin from Serratia marcescens isolated from soil. BMC Microbiol 4: 1-10.
11. Gulder TAM, Moore BS (2009) Chasing the treasures of the sea-bacterial marine natural products. Curr Opin Microbiol 12: 252-260.
12. Kim SJ, Lee HK, Yim JH (2009) Statistical optimization of medium components for the production of prodigiosin by Hahella chejuensis KCTC 2396. J Microbiol Biotechnol 18: 1903-1907.
13. Montaner B, Navarro S, Pique M, Vilaseca M, Martinell M, Giralt E, Gil J, Perez-Tomas R (2000) Prodiogiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines. British J Pharmacol 131(3): 585-593.
14. Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70: 461-477.
15. Perez-Tomas R, Vinas M (2010) New insights on the antitumoral properties of prodiginines. Curr Med Chem 17(21): 2222-2231.
16. Plackett RL, Burman JP (1946) The design of optimum multifactorial experiments. Biometrika 33(4): 305-325.
17. Rocha AB, Lopes RM, Schwartsmann G (2001) Natural products in anticancer therapy. Curr Opin Pharmacol 1: 364-369.
18. Siva R, Subha K, Bhakta D, Ghosh AR, Babu S (2012) Characterization and enhanced production of prodigiosin from the spoiled coconut. Appl Biochem Biotech 166: 187-196.
19. Someya N, Nakajim M, Hamamoto H, Yamaguchi I, Akut K (2004) Effects of light conditions on prodigiosin stability in the biocontrol bacterium Serratia marcescens strain B2. J Gen Plant Pathol 70: 367-370.
20. Su WT, Tsou TY, Liu HL (2011) Response surface optimization of microbial prodigoisins production from Serratia marcescens. J Taiwan Inst Chem Eng 42: 217-222.
21. Urdiales JL, Morata P, Nunez de Castrol I, Sanchez-Jimenez F (1996) Antiproliferative effect of dehydrodidemin B (DDB), a depsipeptide isolated from Mediterranean tunicates. Cancer Lett 102: 31-37.
22. Wang XL, Miao L, Dong KM, Zhou XJ, Jin CL, Qian XQ (2012) The screening and identification of marine bacteria with antitumor activity. J Yangzhou Univ-Agric Life SC 33(2): 18-22.
23. Waters AR, Hill RT, Place AR, Hamann MT (2010) The expanding role of marine microbes in pharmaceutical development. Curr Opin Biotech 21: 780-786.
24. Wei YH, Chen WC (2005) Enhanced production of prodigiosin-like pigment from Serratia marcescens SMΔR by medium improvement and oil-supplementation. J Biosci Bioeng 99(5): 616-622.
25. Wei YH, Yu WJ, Chen WC (2005) Enhanced undecylprodigiosin production from Serratia marcescens SS-1 by medium formulation and amino-acid supplement. J Biosci Bioeng 100(4): 466-471.
26. Zhang LX, An R, Wang JP, Sun N, Zhang S, Hu JC, Kuai J (2005) Exploring novel bioactive compounds from marine microbes. Curr Opin Microbiol 8: 275-281.